Our team has opened a clinical trial evaluating Barrigel, a hyaluronic acid rectal spacer used during prostate cancer radiotherapy.
Rectal spacers are designed to create distance between the prostate and surrounding tissues, potentially reducing side effects and improving the precision of radiation treatment. We look forward to contributing to evidence that improves outcomes for patients with prostate cancer.